- Related Topics:
- anticancer drug
tamoxifen
-
What is tamoxifen?
Tamoxifen is a synthetic hormone primarily used to prevent and treat breast cancer by inhibiting estrogen's growth-promoting actions on breast cancer cells. Initially studied as a contraceptive, it was later found to stimulate ovulation in women, leading to its investigation as a therapy for hormone-dependent cancers.
Tamoxifen, a selective estrogen receptor modulator (SERM), competes with endogenous estrogens for receptor sites in breast tissue, decreasing breast tissue and breast cancer tissue growth. It is taken orally and is the most widely used anticancer drug, also used to treat gynecomastia and infertility in women with anovulatory disorders. Common side effects include nausea, vomiting, hot flashes, and irregular menstruation, with long-term use potentially increasing the risk of uterine cancer and thrombosis.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is tamoxifen used to treat?
Tamoxifen is a synthetic hormone primarily used for the treatment and prevention of breast cancer by blocking estrogen's growth-promoting effects on breast cancer cells. It was initially tested as a contraceptive but was found to stimulate ovulation in women. The U.S. Food and Drug Administration (FDA) approved tamoxifen to treat metastatic estrogen receptor-positive breast cancer in 1978 and to prevent first occurrences of breast cancer in high-risk women in 1998.
Tamoxifen is also sometimes used to treat other conditions, such as gynecomastia in men undergoing antiandrogen therapy for prostate cancer and infertility in women affected by anovulatory disorders.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How does tamoxifen work in the body?
Tamoxifen is a synthetic hormone primarily used to prevent and treat breast cancer by blocking estrogen's growth-promoting effects on breast cancer cells. It is taken orally and functions by competing with natural estrogens for receptor sites in breast tissue.
Normally, estrogen enters a cell and binds to an estrogen receptor, which then moves into the cell nucleus. The estrogenâestrogen receptor complex typically activates genes that produce proteins stimulating cell growth and division. However, when an estrogen receptor binds to tamoxifen, it changes in a way that it can no longer activate genes, which results in a decrease in the growth of breast tissue and breast cancer tissue. Because of its ability to both block and stimulate estrogen activity, tamoxifen is classified as a selective estrogen receptor modulator (SERM).
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What types of cancer are commonly treated with tamoxifen?
Tamoxifen is a synthetic hormone primarily used for the prevention and treatment of breast cancer. It is effective against estrogen receptor-positive breast cancers because it inhibits the growth-promoting actions of estrogen in breast cancer cells. Tamoxifen functions by competing with estrogens for receptor sites in breast tissue, decreasing the growth of breast and breast cancer tissue.
Tamoxifen is also sometimes used to treat other conditions, including gynecomastia in men undergoing antiandrogen therapy for prostate cancer, and infertility in women affected by anovulatory disorders.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What are some possible side effects of tamoxifen?
Tamoxifen, a synthetic hormone primarily for breast cancer prevention and treatment, can cause side effects. Common side effects include nausea, vomiting, hot flashes, and irregular menstruation. High doses or long-term use (over two years) might increase the risk of uterine cancer in some women. Additionally, taking tamoxifen for five or more years as adjuvant therapy can increase the risk of contralateral estrogen receptor-negative breast cancer, a difficult-to-treat form of the disease associated with a poor prognosis. Another serious side effect is an increased risk of thrombosis, potentially requiring anticoagulant treatment. Raloxifene, another selective estrogen-receptor modulator (SERM), may cause hot flashes, leg cramps, and increased risk of deep-vein thrombosis and pulmonary embolism.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
Why is it important to take tamoxifen exactly as prescribed by a doctor?
Tamoxifen is a widely used anticancer drug that treats and prevents breast cancer by inhibiting estrogen's growth-promoting actions in breast cancer cells.
Tamoxifen works by competing with estrogens for receptor sites in breast tissue, decreasing the growth of breast and breast cancer tissue.
It is important to adhere to your doctor's prescribed dosage and schedule when taking tamoxifen. Consistent adherence to the prescribed regimen ensures that the drug maintains the necessary concentration in your body to effectively combat cancer cells. Varying from the prescribed dosage may reduce the drug's effectiveness, potentially leading to treatment failure or increased risk of side effects such as nausea, vomiting, hot flashes, and irregular menstruation.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
tamoxifen, synthetic hormone, used primarily in the prevention and treatment of breast cancer, that inhibits the growth-promoting actions of estrogen in breast cancer cells.
Tamoxifen was first synthesized in 1962 by scientists at the British pharmaceutical company Imperial Chemical Industries PLC (now AstraZeneca). The agent (then known as ICI 46474) was subsequently found to have contraceptive effects in rats and was believed to exert its effects solely through antiestrogen mechanisms. Thus, tamoxifen was initially investigated for potential use as a morning-after pill. However, in the early 1970s, when it was found that tamoxifen had the opposite effect in humansâit actually increased fertility by stimulating ovulation in womenâresearch on the agent as a form of contraception was promptly abandoned.
Several years later scientists recognized the potential application of tamoxifen as a therapy for hormone-dependent cancers and began testing the agent in rats with breast cancer. It was found that tamoxifen exerted antiestrogen effects in breast cancers that expressed estrogen receptors but had no effect in breast cancers that did not express these receptors. Tamoxifenâs complex actions, characterized by its inhibition of estrogen activity in breast tissue and its stimulation of estrogen activity in the endometrium, led to its reclassificationâfrom antiestrogen to selective estrogen receptor modulator (SERM). In 1978, following a series of successful clinical trials in humans, the U.S. Food and Drug Administration (FDA) approved tamoxifen for the treatment of metastatic estrogen receptor-positive breast cancer. In 1998 the FDA further approved the use of tamoxifen for the prevention of first occurrences of breast cancer in women at high risk.
" height="20" alt="HEW Logo">
Tamoxifen is taken orally and works by competing with endogenous estrogens for receptor sites in breast tissue where the estrogens normally exert their actions. Under normal circumstances, estrogen enters a cell and binds to an estrogen receptor, which then diffuses into the cell nucleus. In the nucleus the estrogenâestrogen receptor complex binds to specific sequences of deoxyribonucleic acid (DNA) to activate certain genes. The estrogenâestrogen receptor complex typically activates genes that produce proteins capable of stimulating cell growth and cell division. However, in breast cells, when an estrogen receptor is bound to tamoxifen, its properties are altered in such a way that it can no longer activate genes. The result is a decrease in the growth of breast tissue and of breast cancer tissue. Tamoxifen is ineffective against recurrent breast cancer in about 25 to 35 percent of women. This resistance is believed to be the result of decreased levels of a protein involved in facilitating tamoxifenâs inhibitory effects on gene activation.
Today tamoxifen is the most widely used anticancer drug and is sometimes used to treat other conditions, such as gynecomastia in men undergoing antiandrogen therapy for prostate cancer and infertility in women affected by anovulatory disorders. The most common side effects of tamoxifen include nausea, vomiting, hot flashes, and irregular menstruation. High doses or long-term (more than two years) courses of tamoxifen can increase the risk of uterine cancer in some women. In addition, women who take tamoxifen for five or more years as part of adjuvant therapy (when tamoxifen is used in addition to another agent) have more than a fourfold increase in risk of developing contralateral estrogen receptor-negative breast cancerâa form of the disease that is difficult to treat and is associated with a poor prognosis. Another serious side effect of tamoxifen treatment is an increased risk of thrombosis, which may require patients to take an anticoagulant.